Literature DB >> 12823883

Immunology and immunotherapy in neurosurgical disease.

Robert M Prins1, Linda M Liau.   

Abstract

OBJECTIVE: For many years, the central nervous system (CNS) has been described as "immunologically privileged" and devoid of conventional immune reactivity. However, our more current understanding of neuroimmunology supports a different view. Although immune mechanisms within the CNS may behave differently from those located at peripheral anatomic sites, it is now widely accepted that biologically relevant immune responses can and do occur within the brain and that these responses can play important roles in CNS disease. The objective of this present review is to explore key aspects of recent insights into the cellular interactions involved in neuroimmunology, which may suggest more rational approaches to the immunotherapy of neurosurgical disorders.
CONCLUSION: Modern advances in molecular medicine and basic immunology have yielded a plethora of new data about CNS immunobiology. The design of effective immunotherapeutic strategies for CNS diseases requires a contemporary understanding of the basic tenets of how the immune system works. The current renaissance in this field may give neurosurgeons hope that, in the future, immunotherapy-based paradigms may be able to successfully treat neurosurgical diseases that are currently refractory to traditional therapies.

Entities:  

Mesh:

Year:  2003        PMID: 12823883     DOI: 10.1227/01.neu.0000068865.34216.3a

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  13 in total

1.  CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival.

Authors:  Isaac Yang; Tarik Tihan; Seunggu J Han; Margaret R Wrensch; John Wiencke; Michael E Sughrue; Andrew T Parsa
Journal:  J Clin Neurosci       Date:  2010-08-19       Impact factor: 1.961

2.  Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?

Authors:  Aileen J Anderson; Daniel L Haus; Mitra J Hooshmand; Harvey Perez; Christopher J Sontag; Brian J Cummings
Journal:  Regen Med       Date:  2011-05       Impact factor: 3.806

3.  Transcriptional characterization of immunological infiltrates and their relation with glioblastoma patients overall survival.

Authors:  Mariana Brutschin Pereira; Luciana Rodrigues Carvalho Barros; Paula A Bracco; Alvaro Vigo; Mariana Boroni; Martín Hernán Bonamino; Guido Lenz
Journal:  Oncoimmunology       Date:  2018-02-12       Impact factor: 8.110

4.  Enhanced sensitivity to IL-2 signaling regulates the clinical responsiveness of IL-12-primed CD8(+) T cells in a melanoma model.

Authors:  Dominique N Lisiero; Horacio Soto; Linda M Liau; Robert M Prins
Journal:  J Immunol       Date:  2011-03-23       Impact factor: 5.422

Review 5.  Cellular and vaccine therapeutic approaches for gliomas.

Authors:  Michelle J Hickey; Colin C Malone; Kate L Erickson; Martin R Jadus; Robert M Prins; Linda M Liau; Carol A Kruse
Journal:  J Transl Med       Date:  2010-10-14       Impact factor: 5.531

Review 6.  Current immunotherapeutic strategies for central nervous system tumors.

Authors:  Medina C Kushen; Adam M Sonabend; Maciej S Lesniak
Journal:  Surg Oncol Clin N Am       Date:  2007-10       Impact factor: 3.495

Review 7.  Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human glioma.

Authors:  Gavin P Dunn; Ian F Dunn; William T Curry
Journal:  Cancer Immun       Date:  2007-08-13

8.  B-Cell Depletion with CD20 Antibodies as New Approach in the Treatment of Inflammatory and Immunological Events Associated with Spinal Cord Injury.

Authors:  Giovanna Casili; Daniela Impellizzeri; Marika Cordaro; Emanuela Esposito; Salvatore Cuzzocrea
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

9.  Inflammation and Spinal Cord Injury: Infiltrating Leukocytes as Determinants of Injury and Repair Processes.

Authors:  Alpa Trivedi; Andrea D Olivas; Linda J Noble-Haeusslein
Journal:  Clin Neurosci Res       Date:  2006-12

10.  Interleukin-6 plasmatic levels in patients with head trauma and intracerebral hemorrhage.

Authors:  Alessandra Armstrong Antunes; Vanessa Santos Sotomaior; Keyth Suga Sakamoto; Cyro Pereira de Camargo Neto; Carolina Martins; Luiz Roberto Aguiar
Journal:  Asian J Neurosurg       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.